Hence, a fuller understanding of the detailed molecular mechanisms underlying the disruption of the OTULIN–LUBAC interaction will be instrumental for developing future therapeutic strategies against cancer chemoresistance and necroptotic processes pertinent to numerous human diseases. This evidence concerns the gene OTULIN and cancer.